Neoadjuvant immunotherapy combined with chemotherapy shows promising results in treating limited-stage small cell lung cancer ...

Seegene Inc., a global leader in molecular diagnostics, unveiled two new technologies at ADLM 2025 in Chicago (July 29–31) designed to advance laboratory automation and data-driven infectious disease ...

The new report details Novacyt's product pipeline, offering insights for strategic decision-making in business development and competitive landscapes. Ideal for business and R&D strategies.Dublin, Aug ...

Eastern Europe Molecular Diagnostics Market to reach US$ 1.6 Bn by 2035, growing at 3.2% CAGR, driven by advanced testing adoption and healthcare expansion. WILMINGTON, DE, UNITED STATES, August 23, ...

The laboratory equipment market is expected to grow at a CAGR of ~8% during the forecast period. The growth is driven by rapid technological advancements such as automation and AI, rising R&D in life ...

Multiple positions of cholesterol as it translocates through the common pathway, including the off-pathway intermediate. (a) upright ( δ) (b) tilted ( γ) (c) overtilted ( E ), the off pathway ...

Nifty 50 and Nifty Bank futures show bearish trends, suggesting short positions for traders in the current market scenario.

In this Phase III trial, the Padcev-Keytruda combination used as both neoadjuvant and adjuvant therapy significantly improved event-free and overall survival, as well as pathologic complete response, ...

TRIPLE-NEGATIVE breast cancer (TNBC) remains one of the most aggressive subtypes of breast cancer, with limited targeted treatment options. Neoadjuvant chemoimmunotherapy (NACI) has improved rates of ...